ECM
PFE icon

ExodusPoint Capital Management’s Pfizer PFE Stock Holding History

ExodusPoint Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,700
Closed -$98K – 1875
2024
Q4 		$98K Buy
+3,700
New +$100K ﹤0.01% 1408
2024
Q3 		– Sell
-58,100
Closed -$1.63M – 1982
2024
Q2 		$1.63M Buy
+58,100
New +$1.6M 0.01% 856
2020
Q4 		– Sell
-263,500
Closed -$9.2M – 2288
2020
Q3 		$9.2M Buy
+263,500
New +$9.24M 0.18% 97

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

ExodusPoint Capital Management's PFE Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its Pfizer (PFE) stake by 45% in Q1 2026, selling an estimated $17.7M and leaving 816,068 shares worth $22.9M. The position accounts for 0.18% of the portfolio, ranked #79.

ExodusPoint Capital Management first reported a position in PFE in Q1 2019 and has held it in 21 quarters since. The position peaked at $47.6M in Q1 2025. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • ExodusPoint Capital Management held 816,068 shares of Pfizer worth $22.9M as of Q1 2026.
  • ExodusPoint Capital Management sold 666,483 Pfizer shares in Q1 2026, an estimated $17.7M.
  • Pfizer made up 0.18% of ExodusPoint Capital Management's portfolio in Q1 2026, its #79 holding.
  • ExodusPoint Capital Management first reported a position in Pfizer in Q1 2019 and has held it in 21 quarters since.
  • ExodusPoint Capital Management's Pfizer position peaked at $47.6M in Q1 2025.
  • 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.